BR0113732A - Forma polimórfica da 17-beta-(n-ter. butil carbamoil)-4-aza-5-alfa-androst-1-en-3-ona e processo para sua preparação - Google Patents

Forma polimórfica da 17-beta-(n-ter. butil carbamoil)-4-aza-5-alfa-androst-1-en-3-ona e processo para sua preparação

Info

Publication number
BR0113732A
BR0113732A BR0113732-8A BR0113732A BR0113732A BR 0113732 A BR0113732 A BR 0113732A BR 0113732 A BR0113732 A BR 0113732A BR 0113732 A BR0113732 A BR 0113732A
Authority
BR
Brazil
Prior art keywords
androst
aza
preparation
polymorphic form
tert
Prior art date
Application number
BR0113732-8A
Other languages
English (en)
Portuguese (pt)
Inventor
M Satyanarayana Reddy
S T Rajan
M V N Brahmashwara Rao
K Vyas
S Vishnuvardhana Reddy
K Shashi Rekha
Original Assignee
Reddys Lab Ltd Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddys Lab Ltd Dr filed Critical Reddys Lab Ltd Dr
Publication of BR0113732A publication Critical patent/BR0113732A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR0113732-8A 2000-09-07 2001-06-19 Forma polimórfica da 17-beta-(n-ter. butil carbamoil)-4-aza-5-alfa-androst-1-en-3-ona e processo para sua preparação BR0113732A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN737DE2000 2000-09-07
PCT/US2001/019546 WO2002020553A1 (en) 2000-09-07 2001-06-19 NOVEL POLYMORPHIC FORM OF 17-β-(N-TER.BUTYL CARBAMOYL)-4-AZA-5-α-ANDROST-1-EN-3-ONE AND A PROCESS FOR PREPARING IT

Publications (1)

Publication Number Publication Date
BR0113732A true BR0113732A (pt) 2003-07-29

Family

ID=11097081

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0113732-8A BR0113732A (pt) 2000-09-07 2001-06-19 Forma polimórfica da 17-beta-(n-ter. butil carbamoil)-4-aza-5-alfa-androst-1-en-3-ona e processo para sua preparação

Country Status (12)

Country Link
EP (1) EP1322663A1 (de)
JP (1) JP2004508380A (de)
AU (1) AU6991101A (de)
BR (1) BR0113732A (de)
CA (1) CA2422159A1 (de)
HU (1) HUP0300937A3 (de)
IL (1) IL154785A0 (de)
NO (1) NO20031045L (de)
NZ (1) NZ525116A (de)
PL (1) PL361014A1 (de)
WO (1) WO2002020553A1 (de)
ZA (1) ZA200302554B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2206065B1 (es) * 2002-10-31 2005-08-16 Ragactives, S.L. Procedimiento para la obtencion de la forma polimorfica i de finasterida.
US7550593B2 (en) * 2003-07-03 2009-06-23 Cipla Limited Process for the preparation of finasteride Form I
CN1294913C (zh) * 2004-12-23 2007-01-17 鲁南制药集团股份有限公司 含有非那雄胺与环糊精或其衍生物的药物组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ225100A (en) * 1987-06-29 1991-09-25 Merck & Co Inc Reaction of steroids (including 4-azasteroids) with a silylating agent in the presence of a quinone to introduce a delta' double bond and silylated intermediates
US5237061A (en) * 1988-10-31 1993-08-17 Merck & Co., Inc. Methods of synthesizing benign prostatic hypertropic agents and their intermediates
US5021575A (en) * 1989-11-13 1991-06-04 Merck & Co., Inc. Method for introducing a 1,2 double bond into azasteroids
US5091534A (en) * 1990-08-27 1992-02-25 Merck & Co., Inc. Trialkylsilyl trifluoromethanesulfonate mediated α-methylenic carbon functionalization of 4-AZA-5α-androstan-3-one steroids
US5468860A (en) * 1992-11-19 1995-11-21 Merck & Co., Inc. New finasteride processes

Also Published As

Publication number Publication date
PL361014A1 (en) 2004-09-20
IL154785A0 (en) 2003-10-31
NO20031045D0 (no) 2003-03-06
EP1322663A1 (de) 2003-07-02
HUP0300937A3 (en) 2007-10-29
WO2002020553A1 (en) 2002-03-14
CA2422159A1 (en) 2002-03-14
AU6991101A (en) 2002-03-22
JP2004508380A (ja) 2004-03-18
NO20031045L (no) 2003-04-29
HUP0300937A2 (en) 2007-02-28
ZA200302554B (en) 2004-02-19
NZ525116A (en) 2004-11-26

Similar Documents

Publication Publication Date Title
ECSP095220A (es) Derivados de n-fenil-2-pirimidin-amina
ID29380A (id) Penhilangan konstituen gas asam dari gas
BR0302369A (pt) Conjunto de elementos para estruturas de montagem
EE05198B1 (et) Asendatud aminometlrhma sisaldavad N-(arlsulfonl)beetaaminohappe derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsi£onid
WO2003006425A3 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
BR9900443A (pt) Esteres de ácido aril acrìlico.
DK0750631T3 (da) Mercaptoacetylamido-1,3,4,5-tetrahydrobenzo[c]azepin-3-ondisulfidderivater som enkephalinase- og ACE-inhibitorer
UY27548A1 (es) Sales de ácido succínico de 5,7,14-triazatetraciclo (10.3.1.02.11.04,9) exadeca-2 (11),3,5,7,9-pentaeno y composiciones farmacéuticas
BR0215027A (pt) Derivados de 6-aminomorfinano, processo de preparação para o mesmo e sua aplicação
CA2245267A1 (en) Crystal form of n-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
ES2173179T3 (es) Procedimiento para preparar composiciones de avermectina/ceina.
BR0213481A (pt) Sondas
BR0212772A (pt) Processo para a preparação de repaglinida
BR0301667A (pt) Processo para a preparação de polìmeros em emulsão com pureza elevada
BR0316400A (pt) agentes branqueadores fluorescentes anfotéricos
BR9705456A (pt) Compostos heterocìclicos, processo de aminometila para sua preparação e composições farmacêuticas que os contêm.
BR0113732A (pt) Forma polimórfica da 17-beta-(n-ter. butil carbamoil)-4-aza-5-alfa-androst-1-en-3-ona e processo para sua preparação
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
BR0212153A (pt) Compostos e respectivos processos de preparação e de isolamento de dicloreto de 2-difluormetilornitina
MX9400165A (es) Derivados de ter-butilergolina, proceso para su produccion y composiciones farmaceuticas que los contienen.
BR9712773A (pt) Processo para a sìntese de benzotiofenos
NO20031683L (no) Fremgangsmåte for fremstilling av substituerte anilinforbindelser
PE9296A1 (es) Forma polimorfica cristalina de (s,s,s)- n- (1-[ 2- carboxi- 3-(n�- mesil- lisilamino) propil]- 1-ciclopentil carbonil )tirosina (forma o) y procesos de obtencion
ID27440A (id) Proses untuk menyiapkan penengah-penengah
BR9708963A (pt) Processo para a preparação de ivermectina

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]